13 Penny Stocks with Insider Buying in 2024

Published on May 12, 2024 at 3:26 pm by Fahad Saleem in Hedge Funds, Insider Trading, News

In this article, we will take a detailed look at the 13 Penny Stocks with Insider Buying in 2024. If you want to skip our detailed analysis and see the top 5 stocks in this list, click 5 Penny Stocks with Insider Buying in 2024.

Insider transactions have always drawn market attention as it’s now a well-known fact that when insiders are piling into a stock, the odds of it going higher in the future are pretty bright. Academics all over the world have conducted decades’ worth of research to reach this conclusion. For example, Mervyn King and Aisla Roell at the London School of Economics analyzed insider purchases in the UK stock market from January 1986 through August 1987.

Insider Trades Post Strong Returns in the Long Term

A total of 52 stocks in the dataset posted a 53% return in excess of The Financial Times-Actuaries All Share Index when evaluated one year after insider purchases. These returns shrunk to just about 3% when the time window was narrowed to one month following the insider trade date. That means insiders are long-term investors and they pile into their company shares based on information and growth catalysts that are expected to show their impact in the long term.

How Can Outsides Profit from Insider Trades Triggered by “Special Information”

Another research paper entitled The Linkage between Insider Trading Activities, Market Efficiency, and Stock Information Content cites an extremely useful study, published in 1968 by James H. Lorie and Victor Niederh, which takes a closer look at the connection between insider trading and stock returns. The study, which analyzed 200 large companies during the period from 1962 through 1968, found that insiders do operate with “special information.” However, mimicking insider trades are only profitable in the long term. The results showed that trades with 8-month holding periods “had large returns after transaction cost being taken into account.”

Insiders Don’t Always Enjoy “Superior Success”

However, paying attention to insider trades is a not always profitable. For example, the research by James H. Lorie and Victor Niederh randomly chose 30 companies and analyzed their data and returns from 1961-1964 and during 1957-1960. The results did not show insiders’ tendencies to trade with “superior success.” However, the researchers said complementing insider trades with “proper and prompt” analysis of data and research is useful.

A Vicious Cycle: Insiders Profiting From Market Reaction to Insider Trades?

Over the past several decades the market seems to have accepted that whenever insiders buy a stock it’s bound to go up and when insiders are selling a stock it’s headed for declines in the future. This assumption has in turn created a new opportunity for insiders: they often play the market by profiting from stock movements in response to insider trading activity. Insiders buy or sell their stock to cause a market response to generate profits, creating a vicious circle. This phenomenon was seen by researchers Dan Givoly and Dan Palmon in a study where they analyzed 68 companies listed on the AMEX from 1973 to 1975.

The paper The Linkage between Insider Trading Activities talked about this study:

“The study focused on observing the association between insider transactions and subsequent news disclosure to estimate and detect transactions that yield abnormal returns but did not find any consistent result to show that insiders exploit information about forthcoming news disclosure would realize abnormal gain. However, the result indicated that a significant abnormal return is produced as a result of the trades themselves, promoting the conjecture that public investors accept the superior knowledge and imitate the insiders’ trading behaviors (Givoly and Palmon, 86). In other words, the authors suggested that insiders’ gain might take place after public investors conduct transactions triggered by insiders.”

For this article we used Insider Monkey’s insider trading stock screener to identify penny stocks that saw insider buying activity in 2024. Why should you pay attention to insider trading activity? Insider Monkey’s monthly newsletter and portfolio that focuses on activist hedge funds, insider trading and stock picks from hedge fund investor newsletters and conferences returned 199.2% between March 2017 and March 12, 2024 and outperformed the S&P 500 ETFs’ 144.9% gain by more than 54 percentage points.

13. Marpai Inc (NASDAQ:MRAI)

Number of Hedge Fund Investors: N/A

Health plans services provider Marpai Inc (NASDAQ:MRAI) ranks 13th in our list of the penny stocks with insider buying in 2024. On March 7, 2024, Marpai Inc (NASDAQ:MRAI) CEO Damien Lamendola bought 910,000 shares of Marpai Inc (NASDAQ:MRAI) at $1.65 each. Since this transaction the stock has gained about 60% in value.

12. Flora Growth Corp (NASDAQ:FLGC)

Number of Hedge Fund Investors: 1

Cannabis products company Flora Growth Corp (NASDAQ:FLGC) is one of the penny stocks that saw insider buying this year. On April 8, 2024, Flora Growth Corp’s (NASDAQ:FLGC) CEO Clifford Starke bought 526,315 shares of Flora Growth Corp (NASDAQ:FLGC) at $1.90 per share. Since then the stock has lost about 33% in value.

11. Intrusion Inc. (NASDAQ:INTZ)

Number of Hedge Fund Investors: 3

Texas-based cybersecurity company Intrusion Inc. (NASDAQ:INTZ) is one of the notable penny stocks that recently saw insider purchases. On April 22, 2024, Intrusion Inc.’s (NASDAQ:INTZ) CEO Anthony Scott snapped up 585,748 shares of Intrusion Inc. (NASDAQ:INTZ) at $1.70 per share. Since then through May 8 the stock is down about 3.7%.

10. Modular Medical Inc (NASDAQ:MODD)

Number of Hedge Fund Investors: 5

Development stage medical device company Modular Medical Inc (NASDAQ:MODD) is one of the penny stocks with insider buying in 2024. On February 16, 2024, Manchester Management Co LLC, which has a director status at Modular Medical Inc (NASDAQ:MODD), bought 900,000 shares of Modular Medical Inc (NASDAQ:MODD) at $1.10 per share. Since this transaction the stock price has seen a decline of about 2.3%.

9. Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

Number of Hedge Fund Investors: 8

Clinical stage biopharma company Corvus Pharmaceuticals Inc (NASDAQ:CRVS) ranks ninth in our list of the penny stocks with insider buying in 2024. On May 6, 2024, Richard A. Miller, MD, Corvus Pharmaceuticals Inc’s (NASDAQ:CRVS) CEO, bought 577,634 shares at $1.73 each. Since this transaction, as of May 8, the stock has gained about 2%.

Earlier this month the company talked at length about its pipeline and future plans:

“We plan to begin patient enrollment in our soquelitinib registrational Phase 3 clinical trial in relapsed PTCL in the third quarter of 2024. We are working with or are in advanced discussions with a number of leading centers in the United States and Canada. We anticipate about 40 centers will participate in the trial. The vast majority will be in the United States. Now for an update on soquelitinib for atopic dermatitis, the first immune disease indication we are evaluating. In April, we initiated patient enrollment in the first patient cohort of the trial. There is high interest in our trial from physicians due to several attractive features of soquelitinib. First, this is a first in class drug with a novel mechanism of action. Soquelitinib acts upstream by blocking Th2 and Th17 cells and thereby results in inhibition of many different cytokines involved in disease.

Second, it is an oral therapy and in our cancer studies has been shown to have very good safety profile and third, it may have broad utility across many different autoimmune and inflammatory diseases and this trial may prove provide proof of concept for the treatment of other immune diseases. The trial is designed to enroll 64 patients with moderate to severe atopic dermatitis that have progressed on at least one prior therapy. The study is randomized, placebo controlled and blinded to patients and treating physicians. There will be four sequentially enrolled cohorts of 16 patients, with patients in each cohort being randomized three to one to different dosing regimens of soquelitinib or placebo given for 28 days. The primary endpoint is safety and tolerability and efficacy is measured using investigator global assessments and the clinically validated measurement of improvement in eczema area and severity index score, also known as EASI.”

Read the full earnings call transcript here.

8. Zura Bio Ltd (NASDAQ:ZURA)

Number of Hedge Fund Investors: 10

Zura Bio Ltd (NASDAQ:ZURA) is one of the notable penny stocks that saw heavy insider buying this year. On April 22, 2024, Someit Sidhu, a director at Zura Bio Ltd (NASDAQ:ZURA), piled into 1,186,901 shares at $3.13 each. The total worth of this transaction was about $3.7 million. Since this transaction the stock has gained by a whopping 42%.

7. Absci Corp (NASDAQ:ABSI)

Number of Hedge Fund Investors: 14

Biotech company Absci Corp (NASDAQ:ABSI) is one of the penny stocks with insider buying in 2024. On March 1, 2024, Redmile Group, LLC, a director at Absci Corp (NASDAQ:ABSI), snapped up 222,222 shares at $4.50 each. Since this transaction the stock is down 9%.

6. Tenaya Therapeutics Inc (NASDAQ:TNYA)

Number of Hedge Fund Investors: 14

California-based Tenaya Therapeutics Inc (NASDAQ:TNYA) is one of the penny stocks with insider buying in 2024. On February 12, 2024, David V. Goeddel, a director at Tenaya Therapeutics Inc (NASDAQ:TNYA), piled into a whopping 2,222,222 shares of Tenaya Therapeutics Inc (NASDAQ:TNYA) at $4.50 each. Since then the stock is down 20%.

Click to continue reading and see 5 Penny Stocks with Insider Buying in 2024.

Suggested Articles:

Disclosure. None. 13 Penny Stocks with Insider Buying in 2024 was initially published on Insider Monkey.

Headline NASDAQ:MODD NASDAQ:ZURA NASDAQ:TNYA NASDAQ:MRAI Show more...

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on November 14, 2025 at by Inan Dogan, PhD

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

175 Teslas
107 Amazons
140 Metas
84 Googles
65 Microsofts
And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up